PUBLICATIONS

Using data-driven policy
to build movements

Reports View All
Report 10.29.2024

The Path Forward for a National PrEP Program: Policy and Implementation Priorities

For media inquiries, contact Michael Chancley, Communications and Mobilization Manager, at michael@prep4all.org.  Download: The Path Forward for a National PrEP Program – October 2024 Download One Page Summary of Report This year, PrEP4All convened over 50 PrEP users, providers, community leaders, health department representatives, and researchers from around the country to discuss best practices for […]

Read More
Report 09.12.2024

HIV Activism and US Biosecurity: An After-Action Report on the 2022 Global Mpox Crisis

Download Here. In September 2024, PrEP4All released “HIV Activism and US Biosecurity: An After-Action Report on the 2022 Global Mpox Crisis.” Funded by amfAR and based on in-depth interviews, a national survey and PrEP4All’s experience in collaboratively activating a community response, this report provides a detailed analysis of how HIV activists and frontline providers played […]

Read More
Report 03.14.2024

Toward PrEP Access For All: An analysis of policies, approaches, and strategies in the Southern United States.

In partnership with Southern AIDS Coalition, we’re thrilled to unveil our groundbreaking report, “Toward PrEP Access for All: An analysis of policies, approaches, and strategies in the Southern United States.” This report delves into the crucial steps needed to ensure everyone has equitable access to PrEP. Key Findings: Key barriers to equitable PrEP access A […]

Read More
Report 10.11.2023

PrEP4All M-Pox Alert Series

In Summer 2022, PrEP4All launched our M-Pox Alert Series, a limited series of bulletins containing key information for activists, advocates and impacted communities on the evolving response to the m-pox (formerly known as monkeypox) in the United States and worldwide. Learn more about our ongoing Pandemic and Outbreak Response work here and read past M-Pox Alerts […]

Read More
Report 04.15.2023

Science Held Hostage: How Pharma is Using mRNA Vaccine Contracts With Government to Delay Future Innovation

Clinical trials that are crucial to future pandemic prevention and current responses to SARS CoV-2 are being delayed by pharmaceutical companies. These companies are able to use government contracts specifying when, where and how current vaccines owned by goverments can be used to delay and defer access to these vaccines for research.

Read More
Report 02.07.2023

For Us, By Us: PrEP In Black America: A Master Plan For HIV Prevention In Black America

In the spirit of seeking change to ameliorate the devastating impact of HIV in Black communities through biomedical HIV prevention, Black leaders convened the “PrEP in Black America (PIBA) Summit” dedicated to achieving health equity for Black same gender loving men.

Read More
Loading...
View More